Valuation (41%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 23.30 | -39.04 |
PEG Ratio (TTM) | 0.04 | -2.14 |
P/S Ratio (TTM) | N/A | 51.80 |
P/B Ratio (TTM) | 0.91 | 16.01 |
P/FCF Ratio (TTM) | -958.08 | -212.22 |
Price to 5YR AVG Earnings Ratio | N/A | -39.32 |
Price to 5YR AVG FCF Ratio | -2.48 | -27.27 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.18% | 40.55% |
ROE (TTM) | 2.93% | -488.55% |
Net Profit Margin (TTM) | N/A | -358.55% |
ROIC 5YR AVG | -0.18% | 791.01% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 579.00% | -1.16% | 2,000.24% |
Revenue | -27.60% | -33.33% | -40.00% |
Net Income | 9,956.92% | -24,420.18% | -14,537.00% |
Cash Flow | -126.82% | 180,572,970.87% | 108,343,767.76% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.06 | 2.52 |
Quick Ratio (TTM) | 0.06 | 44.73 |
D/E Ratio (TTM) | 0.10 | 0.17 |
Interest Coverage (TTM) | -5.97 | 3.61 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 2.20 | 21.93 |
LTL to 5YR AVG FCF | N/A | -0.68 |
Shares Outstanding Growth 5YR AVG | 1,120.97% | 488.34% |